HANCE SCARBOROUGH for ALLIANCE FOR PHARMACY COMPOUNDING
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2026 Appropriations. Drug Shortages
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT DAVID PORE | Legislative Director, Cong. Jim Turner |
| THERESA REED | Leg. Director for Multiple Members |
| MICHAEL TOMBERLIN | Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep. Louie Gohmert |
Budget/Appropriations BUD
Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2026 Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT DAVID PORE | Leg. Director for Cong. Jim Turner |
| THERESA REED | Leg. Director for Multiple Members |
| MICHAEL TOMBERLIN | COS for Rep. Chip Cravaack, COS for Rep. Louie Gohmert |
Health Issues HCR
Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2026 Appropriations. Drug Shortages
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT DAVID PORE | Legislative Director, Cong. Jim Turner |
| THERESA REED | Leg. Director for Multiple Members |
| MICHAEL TOMBERLIN | Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep., Louie Gohmert |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.